Maiese W M, Lechevalier M P, Lechevalier H A, Korshalla J, Goodman J, Wildey M J, Kuck N, Conner S D, Greenstein M
Medical Research Division, American Cyanamid Company, Lederle Laboratory, Pearl River, New York 10965.
J Antibiot (Tokyo). 1989 Oct;42(10):1489-93. doi: 10.7164/antibiotics.42.1489.
Antibacterial antibiotics LL-E19020 alpha and beta were isolated from the fermentation broth of an actinomycete strain. Based on cultural and physiological characteristics, culture LL-E19020 was identified as a new subspecies of Streptomyces lydicus. The LL-E19020 alpha and beta antibiotics were found to possess a very narrow antibacterial spectrum against human pathogens. In studies in chickens, LL-E19020 alpha demonstrated excellent growth promoting activity.